100 mg/ml spray for the skin, solution
Ketoprofen
Ketospray Forte contains the active substance ketoprofen, which belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs).
The indication for the use of Ketospray Forte is local, symptomatic treatment of pain and inflammation of soft tissues (including after sprains, strains, and bruises).
The efficacy and safety of using the medicine in children have not been established. Ketospray Forte should not be used in children under 15 years of age.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
The occurrence of interactions between Ketospray Forte, used topically on the skin, and other medicines is unlikely, as the concentration of ketoprofen in the blood after topical application is very low.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult a doctor or pharmacist before using this medicine.
Ketospray Forte should not be used in women during the last three months of pregnancy (III trimester).
During the first six months of pregnancy (I and II trimester), the medicine should not be used unless the doctor considers its use absolutely necessary. If treatment is necessary during this period, the smallest possible dose should be used for the shortest possible time.
The medicine should be used with caution and only in cases where it is absolutely necessary.
Oral forms (e.g., tablets) containing ketoprofen may cause side effects in the unborn child. It is not known whether the same risk is associated with the use of Ketospray Forte on the skin.
It is not known whether ketoprofen passes into breast milk. Therefore, Ketospray Forte should not be used in breastfeeding women.
There is no data on the effect of ketoprofen, used topically on the skin, on the ability to drive vehicles and operate machinery.
100 mg of propylene glycol in 1 ml of liquid. Propylene glycol may cause skin irritation.
This medicine should always be used as directed by your doctor. If you are unsure, you should consult a doctor or pharmacist.
Ketospray Forte is used in adults and children over 15 years of age.
The usual dose is 3 to 6 sprays of the medicine on the affected area, two to three times a day.
The medicine should not be used for more than 7 days. If there is no improvement, you should consult a doctor.
The maximum daily dose is 18 sprays, which corresponds to 360 mg of ketoprofen.
Instructions for using the medicine.
Overdosing on the medicine is unlikely due to the topical route of administration.
In case of using a higher dose of the medicine than recommended, the skin surface should be washed with water.
In case of accidental ingestion of the medicine, systemic side effects of varying severity may occur, depending on the amount of medicine taken (headache and dizziness, nausea, abdominal pain, drowsiness). Ingestion of large doses may cause respiratory depression, coma, convulsions, gastrointestinal bleeding, increased or decreased blood pressure, acute renal failure. There is no specific antidote. In such a case, you should immediately consult a doctor or pharmacist.
If a dose of the medicine is missed, it should be used as soon as possible, and then the usual dosing schedule should be followed.
A double dose should not be used to make up for a missed dose of the medicine.
If you have any further doubts about using this medicine, you should consult a doctor or pharmacist.
Like all medicines, Ketospray Forte can cause side effects, although not everybody gets them.
Side effects after topical use of ketoprofen occur infrequently or rarely. They include allergic skin reactions, severe skin reactions caused by sunlight, and respiratory reactions (there is a possibility of an asthma attack, especially in people allergic to acetylsalicylic acid and/or other NSAIDs). In such cases, the use of the medicine is contraindicated.
Other possible effects (related to the gastrointestinal tract and kidneys) result from the penetration of the active substance through the skin and are therefore dependent on: the dose of ketoprofen used, the skin surface area, the degree of absorption into the tissue, the duration of treatment, and the use or non-use of a dressing.
In some people, during the use of Ketospray Forte, other side effects may occur.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects can help gather more information on the safety of the medicine.
There are no special precautions for storage.
Store in the outer packaging.
Use within 6 months of first opening the packaging.
Store in a place out of sight and reach of children.
Do not use Ketospray Forte after the expiry date stated on the carton and bottle.
The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Ketospray Forte is ketoprofen.
1 ml of the medicine contains 100 mg of ketoprofen.
1 dose from the dispenser (0.2 ml) contains 20 mg of ketoprofen.
Other ingredients of the medicine are: propylene glycol, isopropyl alcohol, macrogol 15 hydroxystearate, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, sodium hydroxide, peppermint oil, purified water.
Ketospray Forte is a colorless to slightly yellowish, clear solution.
It is available in 15 ml and 30 ml bottles made of orange glass, closed with a plastic-metal pump dispenser protected with a cap, containing 12.5 ml and 25 ml of solution, respectively.
The bottles are placed in a cardboard box.
Angelini Pharma Polska Sp. z o.o.
Aleje Jerozolimskie 181B
02-222 Warsaw
tel.: (22) 702 82 00
fax: (22) 702 82 02
e-mail: angelini@angelini.pl
Pharbil Waltrop GmbH
Im Wirrigen 25, D-45731 Waltrop, Germany
Date of last update of the leaflet:
A patient leaflet in a format suitable for the blind and visually impaired is available at the marketing authorization holder's headquarters.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.